Exelixis Inc

Links: Y! EXEL chart/quote @ Y! F

EXEL / Message Board

Written By On Topic Only -- All Messages

Hide Replies

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

MSG #	SUBJECT	TYPE	AUTHOR	SENTIMENT	RECS	DATE POSTED
22233	Re: EXEL Volatility squeeze	GN	mj525252		0	6/19/2019 5:28:21 PM

22232	Re: EXEL Volatility squeeze	GN	wilderguide		4	6/19/2019 5:10:39 PM

22231	EXEL Volatility squeeze	GN	toohearn		5	6/19/2019 3:53:59 PM

22230	Re: First- and second-line treatments for locally advanced renal cell carcinoma	GN	wilderguide		2	6/19/2019 11:39:30 AM

22229	Re: First- and second-line treatments for locally advanced renal cell carcinoma	GN	commonwealthinc		2	6/19/2019 9:46:17 AM

22228	Stifel analyst needs to read patent details before commenting	GN	alias geo		1	6/18/2019 10:32:39 PM

22226	Re: EXEL Patent expiration dates	GN	JoeFlow		1	6/18/2019 10:21:16 PM

22225	Dose-Escalation and Dose-Expansion of RMC-4630 and Cobimetinib in Relapsed/Refractory Solid Tumors	GN	Pacific		2	6/18/2019 10:20:53 PM

22224	First- and second-line treatments for locally advanced renal cell carcinoma	GN	Pacific		3	6/18/2019 9:57:10 PM

22223	Re: EXEL Patent expiration dates	GN	JoeFlow		0	6/18/2019 7:08:31 PM


	About Us • Contact Us • Follow Us on Twitter • Members Directory • Help Center • Advertise Not a member yet? What are you waiting for? Create Account Want to contribute? Support InvestorVillage by donating © 2003-2018 Investorvillage.com. All rights reserved. User Agreement